搜索
LENZ Therapeutics Inc
LENZ添加自选
4.290USD
+0.790+22.57%
收盘 11-09 16:00（美东）
134.79M总市值
亏损市盈率 TTM
关于 LENZ Therapeutics Inc 公司
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.
LENZ Therapeutics Inc 简介
公司代码LENZ
公司名称LENZ Therapeutics Inc
上市日期Jun 25, 2021
CEOSchimmelpennink (Evert)
员工数量42
证券类型Ordinary Share
年结日Jun 25
公司地址- -
城市- -
上市交易所NASDAQ OMX - NASDAQ BASIC
国家- -
邮编- -
电话- -
网址- -
公司代码LENZ
上市日期Jun 25, 2021
CEOSchimmelpennink (Evert)
LENZ Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Marc Odrich
Mr. Marc Odrich
Chief Medical Officer
Chief Medical Officer
100.20K
+0.60%
Dr. Daniel R. (Dan) Chevallard
Dr. Daniel R. (Dan) Chevallard
Interim President and Chief Executive Officer, Chief Financial Officer
Interim President and Chief Executive Officer, Chief Financial Officer
12.89K
+58.20%
Mr. Shawn Olsson
Mr. Shawn Olsson
Chief Commercial Officer
Chief Commercial Officer
4.73K
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Evert (Eef) Schimmelpennink
Mr. Evert (Eef) Schimmelpennink
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
--
--
Dr. Frederic (Fred) Guerard, Pharm.D.
Dr. Frederic (Fred) Guerard, Pharm.D.
Independent Director
Independent Director
--
--
Mr. James Mccollum
Mr. James Mccollum
Independent Director
Independent Director
--
--
Mr. Jeff W. George
Mr. Jeff W. George
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Independent Director
Independent Director
--
--
Dr. Zachary (Zach) Scheiner, Ph.D.
Dr. Zachary (Zach) Scheiner, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Marc Odrich
Mr. Marc Odrich
Chief Medical Officer
Chief Medical Officer
100.20K
+0.60%
Dr. Daniel R. (Dan) Chevallard
Dr. Daniel R. (Dan) Chevallard
Interim President and Chief Executive Officer, Chief Financial Officer
Interim President and Chief Executive Officer, Chief Financial Officer
12.89K
+58.20%
Mr. Shawn Olsson
Mr. Shawn Olsson
Chief Commercial Officer
Chief Commercial Officer
4.73K
--
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Ms. Kimberlee Cobleigh (Kim) Drapkin, CPA
Independent Director
Independent Director
--
--
Mr. Evert (Eef) Schimmelpennink
Mr. Evert (Eef) Schimmelpennink
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
--
--
Dr. Frederic (Fred) Guerard, Pharm.D.
Dr. Frederic (Fred) Guerard, Pharm.D.
Independent Director
Independent Director
--
--
常见问题
LENZ Therapeutics Inc的前五大股东是谁？
LENZ Therapeutics Inc 的前五大股东如下：Mr. Marc Odrich
有多少机构持有LENZ Therapeutics Inc(LENZ)的股份？
截至2026Q1，共有347家机构持有LENZ Therapeutics Inc的股份，合计持有的股份价值约为36.30M，占公司总股份的115.82%。与2025Q4相比，机构持股有所增加，增幅为853081.00。